SUNPHARMA's weekly return of 0.65% was a relatively strong performance, especially compared to its peers. The stock's volatility of 54.03% was higher than average, indicating a riskier investment. Despite this, SUNPHARMA outperformed its peers, including DRREDDY and DIVISLAB, which saw negative returns. However, it underperformed HINDUNILVR, which had a similar return but with much lower volatility.

[Volatility: 54.03%]